Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06516614 · ClinicalTrials.gov registry record · NA

Sleep Coach for Adolescents With Type 1 Diabetes

A NA study of Type 1 Diabetes, sponsored by Vanderbilt University Medical Center.

Recruiting
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT06516614 is a NA study of Type 1 Diabetes that is actively recruiting participants, run by Vanderbilt University Medical Center. The registered enrollment target is 150 participants, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06516614, a NA study of Type 1 Diabetes, is actively recruiting participants, sponsored by Vanderbilt University Medical Center.

RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

The goal of this work is to conduct a randomized trial evaluating the effects of a behavioral intervention to increase sleep duration and quality for adolescents with type 1 diabetes (T1D). The impact of the sleep-promoting intervention on executive function and glycemic outcomes will be assessed. We will also explore multiple components of the recently identified central nervous system glymphatic system and evaluate how these components change and impact brain integrity and function with improved sleep.

Conditions Studied

Interventions

  • BEHAVIORAL Sleep Coach
  • BEHAVIORAL Diabetes Education

Study Locations (1)

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2024-09-18
Est. Completion 2028-09
Phase NA

What the Registry Record Tells You About NCT06516614

The ClinicalTrials.gov registry entry for NCT06516614 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (82% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 1 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Sleep Coach is the first listed.

NCT06516614 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT06516614 about?

NCT06516614 is a clinical study titled "Sleep Coach for Adolescents With Type 1 Diabetes". The goal of this work is to conduct a randomized trial evaluating the effects of a behavioral intervention to increase sleep duration and quality for adolescents with type 1 diabetes (T1D). The impact of the sleep-promoting intervention on executive function and glycemic outcomes will be assessed. W...

What is the current status of trial NCT06516614?

This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2024-09-18. Estimated completion is 2028-09.

What conditions does trial NCT06516614 study?

This clinical trial studies the following conditions: Type 1 Diabetes.

What interventions are being tested in trial NCT06516614?

The interventions under investigation include: Sleep Coach (BEHAVIORAL), Diabetes Education (BEHAVIORAL).

Who is sponsoring clinical trial NCT06516614?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06516614 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 1 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.